Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-11

Clinical Trial Update: KJ-TFC-004 Drug-drug Interaction Study [Phase 1]

View source ↗

Summary

Phase 1 study evaluating drug-drug interactions for KJ-TFC-004 in glaucoma and ocular hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • KJ-TFC-004

Snippet

Sponsor: Kukje Pharma | Conditions: Glaucoma, Eye Diseases | Phase 1 | Status: COMPLETED